首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Ophthalmology

Ophthalmology杂志,由Elsevier Inc.出版,于1978年创刊,Monthly,出版语言English,ISSN:0161-6420,E-ISSN:1549-4713。

投稿咨询
Ophthalmology
Ophthalmology
Ophthalmology
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
10.9
CiteScore
17.2
期刊收录
SCI、SCIE

Ophthalmology(中文译名:《眼科》),ISSN:0161-6420,EISSN:1549-4713,是Elsevier Inc.出版的国际性学术期刊,创刊于1978年,以Monthly形式稳定发行,2026年总发文量约136篇。该刊采用非OA开放访问,学科归属为医学 - 眼科学。该刊是医学、眼科学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达10.9,2025年期刊CiteScore为17.2,2025年期刊自引率约4.6%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Ophthalmology长期聚焦医学、眼科学及相关产业的技术应用前沿,平均审稿周期较快,2-4周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、眼科学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAEngland、Australia、Canada、GERMANY (FED REP GER)、CHINA MAINLAND、Italy等为核心发文国家与地区;UNIVERSITY OF CALIFORNIA SYSTEMUNIVERSITY OF LONDON、HARVARD UNIVERSITY、JOHNS HOPKINS UNIVERSITY、BASCOM PALMER EYE INSTITUTE、DUKE UNIVERSITY、MASSACHUSETTS EYE & EAR INFIRMARY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
OPHTHALMOLOGY 眼科学
1区
是 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
OPHTHALMOLOGY 眼科学
1区
是 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
OPHTHALMOLOGY 眼科学
1区
是 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:OPHTHALMOLOGY SCIE Q1 2 / 98

98.5

学科:OPHTHALMOLOGY SCIE Q1 1 / 98

99.49

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:OPHTHALMOLOGY SCIE Q1 2 / 99

98.5

学科:OPHTHALMOLOGY SCIE Q1 1 / 99

99.49


中国学者近期发文

1
Incidence and Associated Factors of Myopic Maculopathy Progression after Posterior Scleral Contraction in High Myopi

Author:Zhao, Jian; Zhao, Xia; Jiang, Yiqin; Gong, Qianwen; Xue, Anquan; Xu, Xu; Zhu, Shuangqian; Hu, Liang

Journal: OPHTHALMOLOGY. 2026; Vol. 133, Issue 4, pp. 506-514. DOI: 10.1016/j.ophtha.2025.11.002

2
Efficacy and Safety of Spleen Tyrosine Kinase and VEGFR-2 Dual-Target Kinase Inhibitor (OT202) in Dry Eye A Randomized, Vehicle-Controlled Phase 2 Tria

Author:Wang, Haiou; Jin, Xiuming; Zheng, Hongmei; Zhao, Shaozhen; Chen, Luxia; Zhang, Mingchang; Liu, Hai; Xiong, Wei; Li, Li; Wen, Feng; Chen, Wei

Journal: OPHTHALMOLOGY. 2026; Vol. 133, Issue 4, pp. 477-486. DOI: 10.1016/j.ophtha.2025.10.023

3
Global Gender Disparities in Access to Refractive Error Services A Systematic Review and Meta-Analysi

Author:Mavi, Sonia; Whitestone, Noelle; Chan, Ving Fai; Congdon, Nathan; Ramke, Jacqueline; Piyasena, Mapa Prabhath; Gordon, Iris; Patnaik, Jennifer L.; Cherwek, David H.; Negash, Habtamu; Li, Dongfeng; Little, Julie-Anne; Virgili, Gianni

Journal: OPHTHALMOLOGY. 2026; Vol. 133, Issue 2, pp. 257-277. DOI: 10.1016/j.ophtha.2025.08.031

4
Intravitreal Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration: Ninety-Six-Week Results from the Randomized Phase 3 PULSAR Tria

Author:Korobelnik, Jean-Francois; Lanzetta, Paolo; Leal, Sergio; Holz, Frank G.; Clark, W. Lloyd; Eichenbaum, David; Iida, Tomohiro; Sun, Xiaodong; Berliner, Alyson J.; Schulze, Andrea; Zhao, Min; Schmelter, Thomas; Schmidt-Ott, Ursula; Zhang, Xin; Morgan-Warren, Peter; Hasanbasic, Zoran; Vitti, Robert; Chu, Karen W.; Reed, Kimberly; Bhore, Rafia; Cheng, Yenchieh; Bai, Zhanying; Hirshberg, Boaz; Yancopoulos, George D.; Wong, Tien Y

Journal: OPHTHALMOLOGY. 2026; Vol. 133, Issue 1, pp. 39-50. DOI: 10.1016/j.ophtha.2025.08.022

5
Re: Chou et al.: Association between semaglutide and nonarteritic anterior ischemic optic neuropathy: a multinational population-based study (Ophthalmology. 2025:132:381-388

Author:Zhu, Haiying; Zhao, Kun

Journal: OPHTHALMOLOGY. 2025; Vol. 132, Issue 6, pp. e96-e96. DOI:

6
Factual Evidence on Digital Therapeutics in Pediatric Amblyopia Insights into Rapid Axial Elongation Ris

Author:Yao, Ying; He, Yunsi; Wen, Yun; Feng, Lei; Ye, Qingqing; Xu, Zixuan; Zhou, Yusong; Pang, Yangfei; Yu, Wentong; Zhong, Yudan; Li, Qiuying; Yuan, Junpeng; Liu, Jing; Li, Jinrong

Journal: OPHTHALMOLOGY. 2025; Vol. 132, Issue 6, pp. 661-670. DOI: 10.1016/j.ophtha.2025.01.005

7
Re: Cheng et al.: Conbercept versus laser for the treatment of infants with zone II retinopathy of prematurity (Ophthalmology. 2024;131:636-638

Author:Ma, Gang; Sun, Xuequan; Liu, Guangsen

Journal: OPHTHALMOLOGY. 2025; Vol. 132, Issue 6, pp. e97-e98. DOI: 10.1016/j.ophtha.2025.03.004

8
Longitudinal Changes of Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer in Highly Myopic Glaucoma A 3-Year Cohort Stud

Author:Jiang, Jingwen; Kong, Kangjie; Lin, Fengbin; Zhou, Fengqi; Song, Yunhe; Liu, Xiaoyi; Fang, Zige; Xiaokaiti, Dilimulati; Jin, Ling; Chen, Meiling; Jonas, Jost B.; Lam, Dennis S. C.; Zangwill, Linda M.; Sun, Xiaodong; Weinreb, Robert N.; Li, Fei; Zhang, Xiulan

Journal: OPHTHALMOLOGY. 2025; Vol. 132, Issue 6, pp. 644-653. DOI: 10.1016/j.ophtha.2025.01.014

9
Behavioral Intervention with Eye-Use Monitoring to Delay Myopia Onset and Progression in Children A Cluster Randomized Tria

Author:Hu, Yuanyuan; Yu, Mingkun; Han, Xiaotong; Congdon, Nathan; Wu, Ziyun; Liu, Jianping; Liu, Zhaolan; Huo, Huanhuan; Song, Jike; He, Mingguang; Bi, Hongsheng

Journal: OPHTHALMOLOGY. 2025; Vol. 132, Issue 6, pp. 701-712. DOI: 10.1016/j.ophtha.2025.01.003

10
Re: Cheng et al.: Conbercept versus laser for the treatment of infants with zone II retinopathy of prematurity (Ophthalmology. 2024;131:636-638) REPL

Author:Cheng, Yong; Liu, Kailin; Liang, Jianhong

Journal: OPHTHALMOLOGY. 2025; Vol. 132, Issue 6, pp. e98-e99. DOI:


在线咨询

Ophthalmology

国际简称:OPHTHALMOLOGY参考译名:眼科

年发文量:136 CiteScore:17.2 是否预警:否 Gold OA文章占比:22.92% 研究类文章占比:93.38%

杂志社联系方式:ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710

Ophthalmology